NICOTINAMIDE

NICOTINAMIDE was reported 2555 times

NICOTINAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 136 0.4488
1 ANTACID THERAPY 29 0.2231
2 PRESBYACUSIS 51 0.1656
3 SLEEP DISORDER THERAPY 27 0.1364
4 CONGENITAL HIATUS HERNIA 30 0.1316
5 URETHRAL CARUNCLE 8 0.1194
6 MALIGNANT MELANOMA STAGE 0 22 0.1053
7 ANTICOAGULANT THERAPY 29 0.1021
8 ENTEROCOLITIS FUNGAL 3 0.1000
9 NONALCOHOLIC FATTY LIVER DISEASE 19 0.0969
10 MICROSPORIDIA INFECTION 33 0.0940
11 ANALGESIC THERAPY 29 0.0903
12 FEMALE GENITAL TRACT FISTULA 149 0.0872
13 CAPILLARITIS 24 0.0870
14 FACET JOINT SYNDROME 280 0.0859
15 DRUG THERAPY 29 0.0855
16 HEPATIC ENZYME 12 0.0805
17 PLEURAL THICKENING 52 0.0760
18 GAIT SPASTIC 26 0.0758
19 PULMONARY VASCULITIS 40 0.0743
20 SPIROMETRY ABNORMAL 40 0.0669
21 TOTAL LUNG CAPACITY ABNORMAL 26 0.0668
22 ONYCHOMADESIS 274 0.0652
23 CARDIOLIPIN ANTIBODY 2 0.0645
24 MITE ALLERGY 42 0.0641
25 PERIPHERAL VENOUS DISEASE 241 0.0590
26 BLOOD MAGNESIUM INCREASED 52 0.0576
27 NEEDLE FATIGUE 26 0.0569
28 RADICULOPATHY 143 0.0542
29 ONYCHOMYCOSIS 237 0.0540
30 PLEURAL FIBROSIS 52 0.0510
31 BACTEROIDES INFECTION 13 0.0498
32 MYCOTIC ALLERGY 42 0.0491
33 PROCTITIS 136 0.0485
34 APPENDICOLITH 18 0.0465
35 RHEUMATIC FEVER 202 0.0453
36 NICOTINIC ACID DEFICIENCY 5 0.0450
37 DISLOCATION OF VERTEBRA 101 0.0442
38 BONE HYPERTROPHY 7 0.0435
39 CHRONIC SINUSITIS 161 0.0429
40 DUST ALLERGY 42 0.0428
41 C-REACTIVE PROTEIN ABNORMAL 266 0.0414
42 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 29 0.0396
43 FINGER DEFORMITY 186 0.0384
44 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 263 0.0367
45 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 74 0.0357
46 MUSCLE INJURY 286 0.0345
47 LIP DRY 309 0.0340
48 BLEPHAROSPASM 213 0.0338
49 HYPERCHOLESTEROLAEMIA 294 0.0304
50 RELAPSING-REMITTING MULTIPLE SCLEROSIS 26 0.0301
51 BREAST CANCER STAGE III 194 0.0299
52 X-RAY ABNORMAL 53 0.0296
53 PEMPHIGUS 368 0.0294
54 NAIL DISORDER 257 0.0293
55 PRODUCT LABEL CONFUSION 169 0.0290
56 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 3 0.0286
57 CONJUNCTIVITIS ALLERGIC 41 0.0277
58 SALPINGO-OOPHORECTOMY UNILATERAL 3 0.0273
59 NEURITIS 42 0.0272
60 HELICOBACTER INFECTION 277 0.0269
61 DUODENAL ULCER PERFORATION 199 0.0267
62 EPIDERMAL NECROSIS 26 0.0267
63 BONE CYST 25 0.0267
64 PNEUMOCYSTIS JIROVECII INFECTION 31 0.0259
65 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 24 0.0259
66 HYPOCHOLESTEROLAEMIA 9 0.0255
67 FOLLICULITIS 261 0.0249
68 HAND DEFORMITY 314 0.0239
69 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 13 0.0232
70 RHEUMATOID FACTOR POSITIVE 133 0.0230
71 JOINT RANGE OF MOTION DECREASED 307 0.0229
72 DEEP VEIN THROMBOSIS POSTOPERATIVE 45 0.0225
73 RESPIRATORY SYMPTOM 63 0.0221
74 CONGENITAL ANOMALY 168 0.0217
75 RETINITIS 37 0.0214
76 GRIP STRENGTH DECREASED 184 0.0209
77 BACK INJURY 226 0.0208
78 BURSITIS 252 0.0207
79 SWOLLEN JOINT COUNT INCREASED 66 0.0207
80 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 42 0.0206
81 SERONEGATIVE ARTHRITIS 23 0.0201
82 OROPHARYNGITIS FUNGAL 4 0.0198
83 WOUND INFECTION 212 0.0193
84 POSTOPERATIVE RESPIRATORY FAILURE 2 0.0192
85 LUPUS VULGARIS 24 0.0190
86 LIVE BIRTH 158 0.0189
87 NON-ALCOHOLIC FATTY LIVER 6 0.0178
88 SYNOVITIS 310 0.0172
89 MACULAR DEGENERATION 200 0.0167
90 PERICARDITIS 273 0.0162
91 DEAFNESS NEUROSENSORY 53 0.0161
92 OBESITY 253 0.0159
93 OSTEOSCLEROSIS 25 0.0159
94 GLOSSODYNIA 346 0.0154
95 COELIAC DISEASE 151 0.0154
96 ACANTHOLYSIS 1 0.0152
97 INSULIN-LIKE GROWTH FACTOR DECREASED 8 0.0151
98 MALIGNANT FIBROUS HISTIOCYTOMA 2 0.0148
99 HYPERPHOSPHATAEMIA 31 0.0144
100 MONOPARESIS 26 0.0144
101 ACQUIRED PORPHYRIA 1 0.0141
102 NORMOCHROMIC NORMOCYTIC ANAEMIA 42 0.0140
103 IRRITABLE BOWEL SYNDROME 298 0.0139
104 EPIGASTRIC DISCOMFORT 54 0.0138
105 VAGINAL DISCHARGE 138 0.0136
106 RASH PAPULOSQUAMOUS 2 0.0132
107 ADVERSE REACTION 175 0.0132
108 DISABILITY ASSESSMENT SCALE SCORE INCREASED 4 0.0130
109 LOSS OF PROPRIOCEPTION 4 0.0124
110 NORMAL NEWBORN 66 0.0121
111 WOUND 338 0.0121
112 NASAL ODOUR 2 0.0120
113 C-REACTIVE PROTEIN 11 0.0119
114 PIRIFORMIS SYNDROME 2 0.0118
115 LIVER INJURY 285 0.0116
116 INTRACARDIAC MASS 2 0.0113
117 FIBROMYALGIA 270 0.0111
118 BITE 8 0.0111
119 ATROPHIC VULVOVAGINITIS 8 0.0109
120 PARAESTHESIA ORAL 158 0.0109
121 ORAL CANDIDIASIS 144 0.0109
122 TASTE DISORDER 220 0.0108
123 COMA SCALE ABNORMAL 31 0.0107
124 JOINT DESTRUCTION 16 0.0103
125 FORCED EXPIRATORY VOLUME DECREASED 29 0.0102
126 LIVER FUNCTION TEST INCREASED 217 0.0101
127 HYPOPROTHROMBINAEMIA 3 0.0100
128 BLOOD PHOSPHORUS INCREASED 27 0.0099
129 HYPERTONIC BLADDER 27 0.0093
130 PROTHROMBIN TIME RATIO INCREASED 2 0.0092
131 NIGHT SWEATS 294 0.0091
132 OSTEOARTHRITIS 386 0.0091
133 VASCULAR DEVICE OCCLUSION 3 0.0088
134 BONE EROSION 31 0.0088
135 SYSTEMIC LUPUS ERYTHEMATOSUS 305 0.0086
136 CONTRAINDICATED PRODUCT ADMINISTERED 257 0.0085
137 ANAEMIA NEONATAL 4 0.0083
138 IMPAIRED HEALING 272 0.0083
139 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 41 0.0081
140 GAIT INABILITY 267 0.0080
141 BREAST CANCER STAGE II 65 0.0078
142 LIGHT CHAIN ANALYSIS INCREASED 8 0.0077
143 PULMONARY ALVEOLAR HAEMORRHAGE 43 0.0077
144 PLEURITIC PAIN 21 0.0076
145 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 128 0.0075
146 LOWER RESPIRATORY TRACT INFECTION 338 0.0074
147 SPONDYLITIS 27 0.0074
148 NEUROLOGICAL SYMPTOM 42 0.0073
149 EPILEPSY 224 0.0073
150 PULMONARY FIBROSIS 140 0.0073
151 TYPE 2 DIABETES MELLITUS 245 0.0073
152 INFUSION RELATED REACTION 477 0.0072
153 OVERLAP SYNDROME 5 0.0071
154 DAIRY INTOLERANCE 2 0.0071
155 VOCAL CORD POLYP 2 0.0071
156 PHLEBITIS SUPERFICIAL 3 0.0071
157 LUNG DISORDER 332 0.0068
158 INFUSION SITE REACTION 20 0.0067
159 LUNG INJURY 2 0.0066
160 ARTERIOSCLEROSIS CORONARY ARTERY 43 0.0065
161 HEPATITIS 166 0.0065
162 WOUND INFECTION PSEUDOMONAS 2 0.0064
163 EXOSTOSIS 55 0.0060
164 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 4 0.0060
165 PSORIATIC ARTHROPATHY 241 0.0059
166 FREQUENT BOWEL MOVEMENTS 158 0.0058
167 FULL BLOOD COUNT ABNORMAL 61 0.0058
168 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 37 0.0057
169 PRESCRIBED OVERDOSE 110 0.0057
170 BLOOD CHOLESTEROL INCREASED 263 0.0056
171 PNEUMONIA ASPIRATION 140 0.0056
172 PORPHYRIA ACUTE 8 0.0056
173 TINEA VERSICOLOUR 2 0.0056
174 ANTIBODY TEST ABNORMAL 4 0.0056
175 DRUG-INDUCED LIVER INJURY 174 0.0055
176 REGURGITATION 19 0.0055
177 EPIGLOTTITIS 3 0.0055
178 INFLAMMATION 282 0.0055
179 C-REACTIVE PROTEIN INCREASED 198 0.0054
180 WHEEZING 322 0.0054
181 PRESCRIBED UNDERDOSE 108 0.0054
182 APRAXIA 8 0.0054
183 PEMPHIGOID 40 0.0053
184 HEPATIC CONGESTION 5 0.0053
185 RED BLOOD CELL SEDIMENTATION RATE INCREASED 56 0.0051
186 SINUSITIS FUNGAL 4 0.0050
187 THERAPEUTIC PRODUCT EFFECT DECREASED 221 0.0049
188 PROCEDURAL PAIN 136 0.0049
189 SQUAMOUS CELL CARCINOMA OF THE TONGUE 2 0.0049
190 ARTHROPATHY 270 0.0049
191 GIANT CELL ARTERITIS 4 0.0048
192 GASTROOESOPHAGEAL REFLUX DISEASE 385 0.0048
193 OBSTRUCTIVE AIRWAYS DISORDER 53 0.0048
194 ALVEOLAR OSTEITIS 2 0.0047
195 VITAMIN B12 DEFICIENCY 19 0.0047
196 IRON DEFICIENCY 21 0.0047
197 SLEEP DISORDER 328 0.0046
198 DYSPEPSIA 457 0.0046
199 HEPATIC ENZYME INCREASED 315 0.0046
200 INJURY 324 0.0046
201 AORTIC STENOSIS 16 0.0046
202 MUSCULOSKELETAL PAIN 236 0.0045
203 ARTERIOSCLEROSIS 42 0.0045
204 ALDOLASE INCREASED 1 0.0044
205 CYST 54 0.0043
206 URINARY TRACT DISCOMFORT 2 0.0043
207 HYPOPHOSPHATAEMIA 32 0.0043
208 GASTROINTESTINAL STOMA OUTPUT INCREASED 2 0.0043
209 BENIGN PROSTATIC HYPERPLASIA 22 0.0043
210 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 303 0.0043
211 NECK PAIN 238 0.0043
212 MICTURITION URGENCY 48 0.0042
213 VITAMIN B12 DECREASED 12 0.0042
214 DRUG INTOLERANCE 402 0.0042
215 LOWER LIMB FRACTURE 79 0.0041
216 ILL-DEFINED DISORDER 248 0.0041
217 PUSTULAR PSORIASIS 14 0.0041
218 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 69 0.0041
219 BREATH SOUNDS ABNORMAL 20 0.0041
220 NODULE 52 0.0040
221 TROPONIN INCREASED 30 0.0039
222 BLISTER 221 0.0039
223 METASTATIC SQUAMOUS CELL CARCINOMA 2 0.0039
224 AUTOIMMUNE DISORDER 38 0.0039
225 MATERNAL EXPOSURE DURING PREGNANCY 343 0.0038
226 MOBILITY DECREASED 276 0.0038
227 MYASTHENIA GRAVIS 31 0.0038
228 BLOOD POTASSIUM INCREASED 62 0.0038
229 TOTAL LUNG CAPACITY DECREASED 6 0.0038
230 STOMATITIS 226 0.0037
231 RECTAL HAEMORRHAGE 160 0.0037
232 COLITIS 140 0.0037
233 WALKING AID USER 24 0.0036
234 EYE INJURY 11 0.0036
235 PRESBYOPIA 2 0.0036
236 BODY TINEA 2 0.0036
237 OSTEOPENIA 54 0.0036
238 ACUTE POLYNEUROPATHY 1 0.0035
239 COLITIS ULCERATIVE 156 0.0035
240 DRY MOUTH 283 0.0035
241 SPINAL FUSION SURGERY 14 0.0034
242 VASCULITIS 40 0.0034
243 TREATMENT FAILURE 281 0.0034
244 MUSCLE SPASTICITY 41 0.0033
245 SWELLING 312 0.0033
246 MIGRAINE 315 0.0033
247 BLOOD URIC ACID INCREASED 19 0.0033
248 CERUMEN IMPACTION 3 0.0033
249 BLOOD PRESSURE SYSTOLIC ABNORMAL 8 0.0032
250 TOXIC EPIDERMAL NECROLYSIS 49 0.0032
251 MUSCULOSKELETAL STIFFNESS 281 0.0032
252 SCIATICA 51 0.0032
253 BACK DISORDER 51 0.0031
254 ANTINUCLEAR ANTIBODY INCREASED 3 0.0031
255 MUCOSAL DISCOLOURATION 2 0.0031
256 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 2 0.0031
257 BLOOD CHLORIDE DECREASED 8 0.0031
258 RECTAL POLYP 3 0.0030
259 ALOPECIA TOTALIS 1 0.0030
260 JOINT SWELLING 364 0.0030
261 COMA 142 0.0030
262 BLOOD SODIUM INCREASED 8 0.0030
263 NOCTURIA 36 0.0030
264 ULCER HAEMORRHAGE 20 0.0030
265 RHEUMATOID ARTHRITIS 332 0.0029
266 RASH VESICULAR 14 0.0029
267 GASTROINTESTINAL DISORDER 252 0.0028
268 INJECTION SITE REACTION 190 0.0028
269 LUPUS-LIKE SYNDROME 25 0.0028
270 BLOOD PRESSURE DIASTOLIC ABNORMAL 7 0.0027
271 BLOOD PARATHYROID HORMONE INCREASED 8 0.0027
272 HEPATIC CIRRHOSIS 51 0.0027
273 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 130 0.0027
274 BLISTER RUPTURE 2 0.0027
275 HAEMATOCHEZIA 148 0.0027
276 DEFORMITY 25 0.0027
277 INTENTIONAL PRODUCT USE ISSUE 233 0.0027
278 SUSPECTED OFF LABEL USE 12 0.0027
279 POLYARTHRITIS 14 0.0027
280 BLOOD CALCIUM INCREASED 23 0.0026
281 HYPERLIPIDAEMIA 31 0.0026
282 MEMORY IMPAIRMENT 354 0.0026
283 DRUG TOLERANCE 13 0.0026
284 DELIRIUM 89 0.0026
285 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 2 0.0026
286 EXPOSURE DURING PREGNANCY 159 0.0026
287 ABDOMINAL DISTENSION 266 0.0025
288 GENERAL PHYSICAL HEALTH DETERIORATION 294 0.0025
289 DRUG TOLERANCE DECREASED 7 0.0025
290 PANCREATITIS RELAPSING 2 0.0024
291 TROPONIN I INCREASED 4 0.0024
292 SEROUS RETINAL DETACHMENT 2 0.0024
293 DERMATOMYOSITIS 6 0.0024
294 BLOOD TRIGLYCERIDES ABNORMAL 2 0.0023
295 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 2 0.0022
296 OEDEMA 121 0.0022
297 THERAPEUTIC PRODUCT EFFECT DELAYED 10 0.0022
298 ASPIRATION 24 0.0022
299 ATAXIA 26 0.0022
300 ALLERGY TO ARTHROPOD STING 1 0.0022
301 APPENDIX DISORDER 3 0.0021
302 DISCOMFORT 129 0.0021
303 HYPERMETROPIA 2 0.0021
304 OROPHARYNGEAL DISCOMFORT 19 0.0021
305 TUMOUR MARKER INCREASED 10 0.0021
306 RESPIRATORY DISORDER 62 0.0021
307 ANIMAL SCRATCH 2 0.0021
308 NEUROENDOCRINE CARCINOMA OF THE SKIN 2 0.0020
309 CENTRAL NERVOUS SYSTEM LESION 28 0.0020
310 APPENDICITIS 19 0.0020
311 ULNA FRACTURE 2 0.0020
312 HYPERTRANSAMINASAEMIA 14 0.0020
313 ULCER 32 0.0020
314 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
315 SKIN LESION 54 0.0020
316 HYPOAESTHESIA 294 0.0020
317 PERIPHERAL SWELLING 299 0.0019
318 ROAD TRAFFIC ACCIDENT 81 0.0019
319 PARAESTHESIA 297 0.0019
320 CONFUSIONAL STATE 304 0.0019
321 GENERAL SYMPTOM 14 0.0019
322 HAEMOPTYSIS 52 0.0019
323 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
324 SPUTUM INCREASED 4 0.0018
325 LIVER DISORDER 82 0.0018
326 CLAUSTROPHOBIA 2 0.0018
327 BACTERIAL INFECTION 34 0.0018
328 MUSCLE SPASMS 334 0.0018
329 MUCOUS STOOLS 9 0.0018
330 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 4 0.0017
331 GOUT 31 0.0017
332 INFUSION SITE INFECTION 4 0.0017
333 TONGUE HAEMORRHAGE 2 0.0017
334 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
335 FOETAL EXPOSURE DURING PREGNANCY 136 0.0017
336 MYOSITIS 15 0.0017
337 NASAL OEDEMA 3 0.0017
338 ABDOMINAL DISCOMFORT 277 0.0016
339 EMBOLISM VENOUS 5 0.0016
340 END STAGE RENAL DISEASE 30 0.0016
341 XEROSIS 2 0.0016
342 POST-ACUTE COVID-19 SYNDROME 2 0.0016
343 FLUID RETENTION 82 0.0016
344 ABDOMINAL TENDERNESS 8 0.0016
345 HYPERSENSITIVITY 299 0.0016
346 PROTEIN URINE PRESENT 8 0.0016
347 EAR PAIN 31 0.0016
348 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
349 LYMPHADENOPATHY MEDIASTINAL 3 0.0016
350 ADRENAL INSUFFICIENCY 19 0.0016
351 ENDOCRINE DISORDER 2 0.0016
352 NASAL SEPTUM DEVIATION 3 0.0015
353 INCORRECT PRODUCT ADMINISTRATION DURATION 33 0.0015
354 LUNG OPACITY 4 0.0015
355 NASOPHARYNGITIS 278 0.0015
356 BRONCHIECTASIS 10 0.0015
357 HYPERTENSION 313 0.0015
358 INJECTION SITE NECROSIS 3 0.0015
359 UNDERDOSE 106 0.0015
360 MUSCULAR WEAKNESS 165 0.0015
361 VENTRICULAR FIBRILLATION 16 0.0014
362 BLOOD TEST ABNORMAL 20 0.0014
363 NASAL POLYPS 7 0.0014
364 HYPOTHYROIDISM 45 0.0014
365 UPPER RESPIRATORY TRACT INFECTION 65 0.0014
366 PRODUCT QUALITY ISSUE 190 0.0014
367 PELVIC VENOUS THROMBOSIS 2 0.0014
368 HEPATIC STEATOSIS 26 0.0014
369 CONDITION AGGRAVATED 424 0.0014
370 SQUAMOUS CELL CARCINOMA 13 0.0014
371 NODAL RHYTHM 2 0.0014
372 NEURALGIA 33 0.0014
373 GASTROINTESTINAL ULCER 3 0.0014
374 ALOPECIA 265 0.0013
375 KNEE DEFORMITY 2 0.0013
376 HYPERCAPNIA 4 0.0013
377 URTICARIA 222 0.0013
378 ASTIGMATISM 2 0.0013
379 GENITAL HERPES 2 0.0013
380 PRODUCT USE IN UNAPPROVED INDICATION 324 0.0013
381 DIASTOLIC DYSFUNCTION 4 0.0013
382 ABDOMINAL PAIN UPPER 266 0.0013
383 WEIGHT INCREASED 289 0.0013
384 BLOOD CREATININE INCREASED 84 0.0013
385 RIGHT VENTRICULAR FAILURE 9 0.0013
386 HYPOXIA 45 0.0013
387 CONTUSION 121 0.0013
388 NASAL ULCER 2 0.0013
389 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
390 HERPES SIMPLEX 8 0.0012
391 JOINT DISLOCATION 13 0.0012
392 BRONCHITIS CHRONIC 3 0.0012
393 ASPERGILLUS INFECTION 8 0.0012
394 SPINAL CORD DISORDER 2 0.0012
395 TRANSAMINASES INCREASED 27 0.0012
396 RALES 7 0.0012
397 DRY EYE 60 0.0012
398 AMNESIA 78 0.0012
399 PNEUMOCYSTIS JIROVECII PNEUMONIA 12 0.0012
400 ENTEROBACTER INFECTION 2 0.0012
401 CARDIOGENIC SHOCK 17 0.0012
402 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33 0.0012
403 ANAEMIA 222 0.0012
404 RASH PAPULAR 26 0.0012
405 WOUND INFECTION STAPHYLOCOCCAL 2 0.0012
406 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
407 JOINT INJURY 24 0.0011
408 TRANSPLANT DYSFUNCTION 2 0.0011
409 MALAISE 490 0.0011
410 JOINT ARTHROPLASTY 2 0.0011
411 DISABILITY 22 0.0011
412 HIP ARTHROPLASTY 17 0.0011
413 EAR CONGESTION 3 0.0011
414 FOOT DEFORMITY 12 0.0011
415 ABULIA 1 0.0011
416 INFECTION 156 0.0011
417 ADENOCARCINOMA GASTRIC 1 0.0011
418 BLOOD PRESSURE SYSTOLIC INCREASED 21 0.0011
419 IMMUNODEFICIENCY 16 0.0011
420 TUNNEL VISION 2 0.0011
421 JOINT STIFFNESS 28 0.0011
422 BLOOD IRON INCREASED 2 0.0011
423 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
424 PAIN 654 0.0011
425 INSOMNIA 282 0.0011
426 HYPOPROTEINAEMIA 2 0.0011
427 ERECTILE DYSFUNCTION 27 0.0011
428 SLEEP APNOEA SYNDROME 20 0.0010
429 ABDOMINAL PAIN 242 0.0010
430 ESCHERICHIA SEPSIS 3 0.0010
431 ANAL CANCER 1 0.0010
432 ABDOMINAL WALL HAEMATOMA 2 0.0010
433 PAIN IN EXTREMITY 296 0.0010
434 ANAL INCONTINENCE 9 0.0010
435 ASTHMA 113 0.0010
436 ACQUIRED HAEMOPHILIA 1 0.0010
437 NERVE INJURY 11 0.0010
438 DIVERTICULUM 7 0.0010
439 ERUCTATION 19 0.0010
440 TRIGGER FINGER 4 0.0010
441 DERMATITIS PSORIASIFORM 2 0.0010
442 DEPRESSION 222 0.0010
443 WEIGHT FLUCTUATION 10 0.0010
444 URINARY BLADDER HAEMORRHAGE 2 0.0009
445 PRODUCT USE ISSUE 177 0.0009
446 PULMONARY MASS 14 0.0009
447 ALLERGY TO ANIMAL 1 0.0009
448 ANAEMIA MACROCYTIC 2 0.0009
449 CUSHINGOID 3 0.0009
450 SKIN EROSION 3 0.0009
451 BLOOD IRON DECREASED 11 0.0009
452 PRODUCTIVE COUGH 44 0.0009
453 RASH ERYTHEMATOUS 44 0.0009
454 THROMBOSIS 74 0.0009
455 SOMNOLENCE 185 0.0009
456 WEIGHT DECREASED 255 0.0009
457 MOVEMENT DISORDER 29 0.0009
458 PREGNANCY 18 0.0009
459 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
460 CEREBRAL HAEMATOMA 3 0.0009
461 TONGUE ULCERATION 3 0.0009
462 PULMONARY EMBOLISM 83 0.0009
463 OFF LABEL USE 761 0.0009
464 ACUTE PRERENAL FAILURE 1 0.0009
465 METHAEMOGLOBINAEMIA 2 0.0009
466 SINUSITIS 88 0.0009
467 SINUS PAIN 2 0.0009
468 THERAPY NON-RESPONDER 38 0.0008
469 SARCOIDOSIS 4 0.0008
470 FALL 279 0.0008
471 LACUNAR INFARCTION 2 0.0008
472 CONSTIPATION 182 0.0008
473 HYPONATRAEMIA 47 0.0008
474 ERYTHEMA 171 0.0008
475 CARDIOVASCULAR DISORDER 21 0.0008
476 FAECES SOFT 6 0.0008
477 PYREXIA 285 0.0008
478 FOETAL GROWTH RESTRICTION 5 0.0008
479 BREATH ODOUR 2 0.0008
480 HAEMATOLOGICAL INFECTION 2 0.0008
481 PNEUMONIA 264 0.0008
482 NAUSEA 642 0.0008
483 MYOPATHY 7 0.0008
484 ALLERGY TO CHEMICALS 1 0.0008
485 ARTHRALGIA 334 0.0008
486 OSTEOPOROSIS 33 0.0008
487 RASH 349 0.0008
488 PARANASAL SINUS DISCOMFORT 3 0.0008
489 DECREASED APPETITE 184 0.0008
490 THERAPEUTIC RESPONSE DECREASED 48 0.0008
491 KLEBSIELLA INFECTION 4 0.0008
492 AORTIC ARTERIOSCLEROSIS 2 0.0008
493 FAECES HARD 3 0.0008
494 ACTINIC KERATOSIS 2 0.0008
495 DYSARTHRIA 29 0.0008
496 POLLAKIURIA 32 0.0008
497 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40 0.0008
498 KNEE ARTHROPLASTY 16 0.0008
499 CEREBRAL ATROPHY 3 0.0008
500 EAR INFECTION 20 0.0008
501 DIARRHOEA HAEMORRHAGIC 7 0.0007
502 ADVERSE EVENT 69 0.0007
503 DYSPNOEA 422 0.0007
504 BREAST CANCER METASTATIC 8 0.0007
505 RENAL IMPAIRMENT 62 0.0007
506 ABNORMAL FAECES 6 0.0007
507 ECCHYMOSIS 5 0.0007
508 ASTHENIA 274 0.0007
509 SPINAL STENOSIS 3 0.0007
510 VITAMIN D DEFICIENCY 7 0.0007
511 CORONARY ARTERY DISEASE 21 0.0007
512 DIVERTICULUM INTESTINAL 3 0.0007
513 CHEST PAIN 127 0.0007
514 WRONG PATIENT RECEIVED PRODUCT 2 0.0007
515 ASCITES 20 0.0007
516 TOOTH DISCOLOURATION 2 0.0007
517 HEADACHE 426 0.0007
518 GROWTH RETARDATION 2 0.0007
519 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
520 ANKLE OPERATION 1 0.0007
521 CARDIAC PACEMAKER INSERTION 4 0.0007
522 ATYPICAL PNEUMONIA 2 0.0007
523 HEART RATE IRREGULAR 15 0.0007
524 OEDEMA PERIPHERAL 80 0.0007
525 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
526 VOMITING 302 0.0006
527 BLOOD BLISTER 2 0.0006
528 INVESTIGATION 2 0.0006
529 SKIN ABRASION 3 0.0006
530 BLADDER PAIN 2 0.0006
531 POLYMYALGIA RHEUMATICA 2 0.0006
532 BLOOD PRESSURE FLUCTUATION 15 0.0006
533 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
534 LYMPHOCYTE COUNT DECREASED 11 0.0006
535 BRADYCARDIA 33 0.0006
536 HIATUS HERNIA 8 0.0006
537 ADVERSE DRUG REACTION 55 0.0006
538 LISTLESS 2 0.0006
539 HOSPITALISATION 93 0.0006
540 HYPERGLYCAEMIA 22 0.0006
541 LYME DISEASE 2 0.0006
542 BLOOD UREA INCREASED 10 0.0006
543 WOUND COMPLICATION 2 0.0006
544 DIZZINESS 281 0.0006
545 GLOSSITIS 2 0.0006
546 DIARRHOEA 362 0.0006
547 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
548 THROMBOCYTOSIS 2 0.0005
549 IRON DEFICIENCY ANAEMIA 5 0.0005
550 CARDIOMYOPATHY 8 0.0005
551 URINARY INCONTINENCE 16 0.0005
552 PLATELET COUNT INCREASED 7 0.0005
553 DRUG INEFFECTIVE 697 0.0005
554 SPUTUM DISCOLOURED 5 0.0005
555 RED BLOOD CELL COUNT DECREASED 15 0.0005
556 CLAVICLE FRACTURE 2 0.0005
557 HAEMOGLOBIN DECREASED 53 0.0005
558 INTENTIONAL PRODUCT MISUSE 45 0.0005
559 BASAL CELL CARCINOMA 8 0.0005
560 ACUTE HEPATIC FAILURE 7 0.0005
561 WOUND SECRETION 2 0.0005
562 PROSTATOMEGALY 2 0.0005
563 FATIGUE 396 0.0005
564 FAECES DISCOLOURED 11 0.0005
565 HAEMATOCRIT DECREASED 10 0.0005
566 TRICUSPID VALVE INCOMPETENCE 4 0.0005
567 CANDIDIASIS 2 0.0005
568 DIABETES MELLITUS 38 0.0005
569 TACHYCARDIA 44 0.0005
570 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
571 HYPERURICAEMIA 2 0.0005
572 BALANCE DISORDER 42 0.0005
573 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
574 CANDIDA INFECTION 8 0.0005
575 PURULENT DISCHARGE 2 0.0005
576 PROCTALGIA 3 0.0005
577 PSEUDOMONAS INFECTION 4 0.0005
578 TENSION HEADACHE 2 0.0005
579 HYSTERECTOMY 4 0.0005
580 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
581 POLYP 3 0.0005
582 RASH MACULO-PAPULAR 10 0.0004
583 RHINITIS ALLERGIC 2 0.0004
584 ANXIETY 127 0.0004
585 COLITIS ISCHAEMIC 3 0.0004
586 VASCULAR DEVICE INFECTION 2 0.0004
587 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
588 SCAB 5 0.0004
589 CROHN'S DISEASE 3 0.0004
590 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
591 LOCALISED OEDEMA 2 0.0004
592 SKIN REACTION 6 0.0004
593 SKIN TIGHTNESS 2 0.0004
594 VAGINAL INFECTION 2 0.0004
595 SPINAL COLUMN STENOSIS 2 0.0004
596 NEUROPATHY PERIPHERAL 40 0.0004
597 KIDNEY TRANSPLANT REJECTION 2 0.0004
598 DERMATITIS BULLOUS 3 0.0004
599 MOUTH HAEMORRHAGE 3 0.0004
600 MULTIPLE SCLEROSIS RELAPSE 28 0.0004
601 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
602 STAPHYLOCOCCAL SEPSIS 2 0.0004
603 HYPERNATRAEMIA 2 0.0004
604 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
605 LEUKOPENIA 20 0.0004
606 EMPHYSEMA 4 0.0004
607 AORTIC ANEURYSM 3 0.0004
608 GAIT DISTURBANCE 75 0.0004
609 SKIN DISCOLOURATION 18 0.0004
610 WEIGHT LOSS POOR 2 0.0004
611 HYPOPHAGIA 10 0.0004
612 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
613 ENDOCARDITIS 2 0.0004
614 DRUG RESISTANCE 10 0.0004
615 CACHEXIA 2 0.0004
616 LIMB DISCOMFORT 12 0.0004
617 POOR VENOUS ACCESS 4 0.0004
618 HYPERBILIRUBINAEMIA 4 0.0004
619 EYE DISCHARGE 4 0.0004
620 PETECHIAE 4 0.0004
621 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
622 DISEASE PROGRESSION 45 0.0004
623 FOOD CRAVING 2 0.0004
624 PREMATURE DELIVERY 6 0.0004
625 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
626 TRANSPLANT REJECTION 3 0.0004
627 SKIN LACERATION 4 0.0004
628 PERIPHERAL COLDNESS 5 0.0004
629 HYPERKERATOSIS 2 0.0004
630 PSORIASIS 47 0.0004
631 CARPAL TUNNEL SYNDROME 5 0.0004
632 HEPATOCELLULAR INJURY 5 0.0004
633 SEPSIS 39 0.0003
634 OVERDOSE 75 0.0003
635 CARDIAC MURMUR 3 0.0003
636 HYPOKALAEMIA 16 0.0003
637 SKIN WARM 2 0.0003
638 MEDICATION ERROR 19 0.0003
639 HEART RATE DECREASED 12 0.0003
640 SPINAL OSTEOARTHRITIS 3 0.0003
641 HEAD DISCOMFORT 6 0.0003
642 ENERGY INCREASED 2 0.0003
643 CHOLELITHIASIS 11 0.0003
644 HAEMOLYTIC ANAEMIA 3 0.0003
645 POLYNEUROPATHY 4 0.0003
646 DERMATITIS ACNEIFORM 2 0.0003
647 BRONCHITIS 24 0.0003
648 TENDONITIS 5 0.0003
649 DYSPNOEA EXERTIONAL 12 0.0003
650 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
651 BLOOD URINE PRESENT 6 0.0003
652 FOREIGN BODY SENSATION IN EYES 2 0.0003
653 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
654 HEPATITIS ACUTE 2 0.0003
655 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
656 ANKYLOSING SPONDYLITIS 4 0.0003
657 LIGAMENT SPRAIN 3 0.0003
658 OXYGEN SATURATION DECREASED 17 0.0003
659 SALIVARY HYPERSECRETION 3 0.0003
660 POST-TRAUMATIC STRESS DISORDER 2 0.0003
661 BREAST MASS 2 0.0003
662 PLEURAL EFFUSION 18 0.0003
663 IMPAIRED GASTRIC EMPTYING 4 0.0003
664 BREAST CANCER 27 0.0003
665 LYMPHOEDEMA 2 0.0003
666 AUTOIMMUNE HEPATITIS 2 0.0003
667 APHONIA 4 0.0003
668 HEAD INJURY 9 0.0003
669 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
670 FLATULENCE 16 0.0003
671 BODY HEIGHT DECREASED 3 0.0003
672 FEAR OF INJECTION 2 0.0003
673 RASH PRURITIC 15 0.0003
674 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
675 AMYLASE INCREASED 1 0.0003
676 CEREBRAL DISORDER 2 0.0003
677 BLOOD PRESSURE INCREASED 41 0.0003
678 MALNUTRITION 3 0.0003
679 SKIN INFECTION 3 0.0003
680 LOSS OF CONSCIOUSNESS 34 0.0003
681 HYPOAESTHESIA ORAL 4 0.0003
682 HAEMODYNAMIC INSTABILITY 2 0.0003
683 HYPERTHERMIA 2 0.0003
684 LIPASE INCREASED 2 0.0003
685 LETHARGY 15 0.0003
686 GASTRIC HAEMORRHAGE 3 0.0003
687 CELLULITIS 13 0.0003
688 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
689 APHTHOUS ULCER 2 0.0003
690 CAESAREAN SECTION 3 0.0003
691 HYPOALBUMINAEMIA 2 0.0003
692 APNOEA 2 0.0003
693 HAEMORRHOIDS 5 0.0003
694 DIVERTICULITIS 7 0.0003
695 BLOOD ALBUMIN DECREASED 2 0.0003
696 ATRIAL FLUTTER 2 0.0003
697 DRUG INTERACTION 39 0.0002
698 SUBSTANCE ABUSE 2 0.0002
699 PRURITUS 94 0.0002
700 ESCHERICHIA INFECTION 2 0.0002
701 INJECTION SITE EXTRAVASATION 3 0.0002
702 MANIA 4 0.0002
703 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
704 SPINAL COMPRESSION FRACTURE 2 0.0002
705 ANOREXIA 3 0.0002
706 BLOOD MAGNESIUM DECREASED 2 0.0002
707 MUSCLE STRAIN 2 0.0002
708 RESPIRATORY TRACT INFECTION 6 0.0002
709 ARTHRITIS 18 0.0002
710 TOOTH INFECTION 3 0.0002
711 TUMOUR LYSIS SYNDROME 2 0.0002
712 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
713 PURPURA 2 0.0002
714 VISUAL IMPAIRMENT 28 0.0002
715 DRUG ERUPTION 4 0.0002
716 HEPATOTOXICITY 5 0.0002
717 THIRST 4 0.0002
718 GASTROINTESTINAL INFECTION 2 0.0002
719 SINUS CONGESTION 3 0.0002
720 GASTROENTERITIS VIRAL 4 0.0002
721 NEUTROPENIA 30 0.0002
722 ACCIDENTAL OVERDOSE 8 0.0002
723 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
724 GRAND MAL CONVULSION 2 0.0002
725 INTESTINAL OBSTRUCTION 8 0.0002
726 BLOOD SODIUM DECREASED 4 0.0002
727 STAPHYLOCOCCAL INFECTION 7 0.0002
728 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
729 LYMPHOPENIA 3 0.0002
730 SEASONAL ALLERGY 3 0.0002
731 HYPOCALCAEMIA 4 0.0002
732 BLOOD PRESSURE DECREASED 14 0.0002
733 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
734 MUSCULOSKELETAL DISORDER 4 0.0002
735 HYPOTENSION 42 0.0002
736 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
737 HYPOGLYCAEMIA 10 0.0002
738 TREMOR 34 0.0002
739 HAEMATURIA 7 0.0002
740 LABORATORY TEST ABNORMAL 6 0.0002
741 BODY TEMPERATURE DECREASED 2 0.0002
742 AGEUSIA 5 0.0002
743 DEEP VEIN THROMBOSIS 13 0.0002
744 TOXIC SKIN ERUPTION 2 0.0002
745 PRODUCT ADMINISTRATION ERROR 4 0.0002
746 SUICIDE ATTEMPT 12 0.0002
747 BLINDNESS 8 0.0002
748 BODY TEMPERATURE INCREASED 4 0.0002
749 AMMONIA INCREASED 1 0.0002
750 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
751 OROPHARYNGEAL PAIN 18 0.0002
752 ANKLE FRACTURE 3 0.0002
753 CARDIO-RESPIRATORY ARREST 8 0.0002
754 MOUTH ULCERATION 4 0.0002
755 RENAL PAIN 2 0.0002
756 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
757 CYSTITIS 6 0.0002
758 EYE SWELLING 7 0.0002
759 HEREDITARY ANGIOEDEMA 2 0.0002
760 POOR QUALITY SLEEP 4 0.0002
761 SKIN CANCER 4 0.0002
762 DECREASED ACTIVITY 2 0.0002
763 MUSCLE TIGHTNESS 3 0.0002
764 LIMB INJURY 5 0.0002
765 TREATMENT NONCOMPLIANCE 10 0.0002
766 HEART RATE INCREASED 18 0.0002
767 VENTRICULAR TACHYCARDIA 3 0.0002
768 RESPIRATORY DISTRESS 5 0.0002
769 CYTOMEGALOVIRUS INFECTION 3 0.0002
770 FUNGAL INFECTION 6 0.0002
771 SKIN DISORDER 6 0.0002
772 FEELING COLD 5 0.0002
773 FEELING HOT 11 0.0002
774 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
775 FISTULA 2 0.0002
776 SKIN EXFOLIATION 15 0.0002
777 REBOUND EFFECT 2 0.0002
778 CHOLECYSTECTOMY 2 0.0002
779 MUSCULOSKELETAL DISCOMFORT 3 0.0002
780 ORTHOSTATIC HYPOTENSION 3 0.0002
781 LIVER FUNCTION TEST ABNORMAL 5 0.0002
782 NEUTROPHIL COUNT DECREASED 7 0.0002
783 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
784 CHILLS 20 0.0002
785 LYMPHADENOPATHY 6 0.0002
786 ISCHAEMIC STROKE 3 0.0002
787 WRIST FRACTURE 2 0.0002
788 BLOOD GLUCOSE DECREASED 8 0.0002
789 BLOOD POTASSIUM DECREASED 5 0.0002
790 LOCALISED INFECTION 4 0.0002
791 PANIC ATTACK 6 0.0002
792 SEPTIC SHOCK 7 0.0002
793 MIDDLE INSOMNIA 3 0.0002
794 MYOCARDIAL INFARCTION 28 0.0002
795 BRAIN OEDEMA 2 0.0002
796 CHRONIC KIDNEY DISEASE 12 0.0002
797 INTRAOCULAR PRESSURE INCREASED 2 0.0002
798 GLAUCOMA 3 0.0002
799 NO ADVERSE EVENT 28 0.0002
800 ATRIAL FIBRILLATION 15 0.0002
801 SKIN FISSURES 3 0.0002
802 OSTEONECROSIS 5 0.0002
803 GASTRITIS 4 0.0002
804 SINUS DISORDER 3 0.0002
805 PANCREATITIS 8 0.0002
806 MALIGNANT MELANOMA 2 0.0001
807 QUALITY OF LIFE DECREASED 2 0.0001
808 FULL BLOOD COUNT DECREASED 3 0.0001
809 UVEITIS 2 0.0001
810 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
811 RIB FRACTURE 3 0.0001
812 INTERSTITIAL LUNG DISEASE 7 0.0001
813 HYPOMAGNESAEMIA 2 0.0001
814 MASS 2 0.0001
815 PRODUCT DOSE OMISSION ISSUE 42 0.0001
816 DIALYSIS 2 0.0001
817 HERPES ZOSTER 8 0.0001
818 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
819 HYPOKINESIA 2 0.0001
820 PRODUCT PRESCRIBING ISSUE 3 0.0001
821 FLUID OVERLOAD 2 0.0001
822 MELAENA 3 0.0001
823 APPLICATION SITE PAIN 3 0.0001
824 SKIN HAEMORRHAGE 2 0.0001
825 THROMBOCYTOPENIA 15 0.0001
826 PANCREATITIS ACUTE 3 0.0001
827 CHROMATURIA 3 0.0001
828 COUGH 37 0.0001
829 PLATELET COUNT DECREASED 14 0.0001
830 ACIDOSIS 1 0.0001
831 MUSCULOSKELETAL CHEST PAIN 2 0.0001
832 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
833 THERAPY PARTIAL RESPONDER 2 0.0001
834 NERVOUS SYSTEM DISORDER 4 0.0001
835 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
836 BRAIN FOG 2 0.0001
837 AFFECTIVE DISORDER 1 0.0001
838 CYANOSIS 2 0.0001
839 PRODUCT USE COMPLAINT 2 0.0001
840 DISEASE RECURRENCE 6 0.0001
841 BACK PAIN 29 0.0001
842 LACTIC ACIDOSIS 4 0.0001
843 CEREBRAL INFARCTION 3 0.0001
844 DRUG LEVEL INCREASED 2 0.0001
845 EPISTAXIS 9 0.0001
846 VIRAL INFECTION 4 0.0001
847 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
848 HAEMATOMA 3 0.0001
849 DEAFNESS 3 0.0001
850 ECZEMA 6 0.0001
851 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
852 FEELING ABNORMAL 27 0.0001
853 JAUNDICE 3 0.0001
854 OSTEOMYELITIS 2 0.0001
855 SUICIDAL IDEATION 10 0.0001
856 DYSURIA 4 0.0001
857 CONJUNCTIVITIS 2 0.0001
858 AGRANULOCYTOSIS 2 0.0001
859 HOT FLUSH 8 0.0001
860 MYALGIA 18 0.0001
861 FRACTURE 2 0.0001
862 URINARY TRACT INFECTION 18 0.0001
863 FOOT FRACTURE 2 0.0001
864 OCULAR HYPERAEMIA 5 0.0001
865 INTENTIONAL DOSE OMISSION 3 0.0001
866 DEHYDRATION 14 0.0001
867 DRY SKIN 14 0.0001
868 AFFECT LABILITY 1 0.0001
869 DYSPHONIA 6 0.0001
870 SURGERY 6 0.0001
871 DEATH 88 0.0001
872 KIDNEY INFECTION 2 0.0001
873 CATARACT 6 0.0001
874 BLOOD PRESSURE ABNORMAL 2 0.0001
875 ABORTION SPONTANEOUS 4 0.0001
876 PREMATURE BABY 3 0.0001
877 HEPATIC FAILURE 3 0.0001
878 APHASIA 3 0.0001
879 ACUTE KIDNEY INJURY 15 0.0001
880 EMOTIONAL DISORDER 3 0.0001
881 PULMONARY HYPERTENSION 2 0.0001
882 DERMATITIS ATOPIC 5 0.0001
883 DYSPHAGIA 9 0.0001
884 EATING DISORDER 2 0.0001
885 IMPAIRED WORK ABILITY 2 0.0001
886 INTENTIONAL OVERDOSE 6 0.0001
887 PRURITUS GENERALISED 2 0.0001
888 SWELLING FACE 6 0.0001
889 EYE DISORDER 3 0.0001
890 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
891 STEVENS-JOHNSON SYNDROME 2 0.0001
892 PANCYTOPENIA 5 0.0001
893 EYE PRURITUS 3 0.0001
894 THROAT IRRITATION 4 0.0001
895 ANGER 3 0.0001
896 GASTRIC DISORDER 3 0.0001
897 NEPHROLITHIASIS 4 0.0001
898 CARDIAC FAILURE 7 0.0001
899 TINNITUS 4 0.0001
900 EYE IRRITATION 5 0.0001
901 MUSCLE TWITCHING 2 0.0001
902 PERICARDIAL EFFUSION 2 0.0001
903 RENAL DISORDER 4 0.0001
904 BURNING SENSATION 6 0.0001
905 HYPERKALAEMIA 3 0.0001
906 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
907 ACCIDENT 1 0.0001
908 CRYING 3 0.0001
909 AGITATION 6 0.0001
910 ENCEPHALOPATHY 2 0.0001
911 INJECTION SITE MASS 3 0.0001
912 HAEMATEMESIS 2 0.0001
913 UNRESPONSIVE TO STIMULI 2 0.0001
914 PALPITATIONS 9 0.0001
915 ABNORMAL BEHAVIOUR 3 0.0001
916 DISORIENTATION 3 0.0001
917 DEPRESSED MOOD 4 0.0001
918 FEBRILE NEUTROPENIA 5 0.0001
919 NEOPLASM MALIGNANT 5 0.0001
920 DRUG EFFECT DECREASED 4 0.0001
921 BLOOD BILIRUBIN INCREASED 2 0.0001
922 PNEUMONITIS 2 0.0001
923 LUNG NEOPLASM MALIGNANT 3 0.0001
924 INFLUENZA LIKE ILLNESS 6 0.0001
925 VISION BLURRED 10 0.0001
926 INFLUENZA 8 0.0001
927 TOXICITY TO VARIOUS AGENTS 12 0.0001
928 EYE PAIN 4 0.0001
929 PAIN IN JAW 2 0.0001
930 HYPOACUSIS 3 0.0001
931 SEIZURE 8 0.0001
932 DEVICE DISLOCATION 3 0.0001
933 MENTAL DISORDER 3 0.0001
934 FLUSHING 7 0.0001
935 PULMONARY OEDEMA 3 0.0001
936 LACRIMATION INCREASED 2 0.0001
937 COGNITIVE DISORDER 3 0.0001
938 ABSCESS 1 0.0001
939 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
940 RENAL FAILURE 8 0.0001
941 LIP SWELLING 2 0.0001
942 URINARY RETENTION 2 0.0001
943 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
944 CHEST DISCOMFORT 6 0.0001
945 BLOOD GLUCOSE INCREASED 11 0.0001
946 SPEECH DISORDER 3 0.0001
947 RASH MACULAR 2 0.0001
948 HEPATIC FUNCTION ABNORMAL 2 0.0001
949 ACUTE RESPIRATORY FAILURE 1 0.0001
950 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
951 IRRITABILITY 3 0.0000
952 VERTIGO 3 0.0000
953 CARDIAC ARREST 4 0.0000
954 RHABDOMYOLYSIS 2 0.0000
955 CEREBROVASCULAR ACCIDENT 8 0.0000
956 RENAL FAILURE ACUTE 2 0.0000
957 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
958 VAGINAL HAEMORRHAGE 2 0.0000
959 PRODUCT DOSE OMISSION 3 0.0000
960 COVID-19 8 0.0000
961 ANGIOEDEMA 2 0.0000
962 INCORRECT DOSE ADMINISTERED 10 0.0000
963 SKIN IRRITATION 2 0.0000
964 THERAPY INTERRUPTED 3 0.0000
965 SYNCOPE 4 0.0000
966 THERAPY CESSATION 2 0.0000
967 ILLNESS 4 0.0000
968 HAEMORRHAGE 4 0.0000
969 INJECTION SITE BRUISING 3 0.0000
970 CARDIAC FAILURE CONGESTIVE 3 0.0000
971 DISTURBANCE IN ATTENTION 2 0.0000
972 ANAPHYLACTIC REACTION 2 0.0000
973 COMPLETED SUICIDE 3 0.0000
974 CONVULSION 2 0.0000
975 PRODUCT STORAGE ERROR 3 0.0000
976 NASAL CONGESTION 2 0.0000
977 ACUTE MYOCARDIAL INFARCTION 1 0.0000
978 EMOTIONAL DISTRESS 4 0.0000
979 INJECTION SITE PRURITUS 2 0.0000
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
982 RESPIRATORY FAILURE 2 0.0000
983 UNEVALUABLE EVENT 2 0.0000
984 INJECTION SITE SWELLING 2 0.0000
985 INJECTION SITE PAIN 8 0.0000
986 INJECTION SITE ERYTHEMA 3 0.0000
987 DRUG WITHDRAWAL SYNDROME 2 0.0000
988 DRUG DOSE OMISSION 3 0.0000
989 DRUG DEPENDENCE 2 0.0000